The movement to make data from clinical trials widely accessible has achieved enormous success, and it is now time for medical journals to play their part. From 1 July The BMJ will extend its requirements for data sharing to apply to all submitted clinical trials, not just those that test drugs or devices. The data transparency revolution is gathering pace. Last month, the World Health Organization (WHO) and the Nordic Trial Alliance released important declarations about clinical trial transparency.
See full Editorial at http://www.bmj.com/content/350/bmj.h2373
No comments:
Post a Comment